overweight and obesity - epidemiology forecast to 2022 · reference code gdhcer022 | publication...
TRANSCRIPT
REFERENCE CODE GDHCER022 | PUBLICAT ION DATE AUGUST 2013
OVERWEIGHT AND OBESITY - EPIDEMIOLOGY FORECAST TO 2022
Overweight and Obesity - Epidemiology Forecast to 2022 2 © GlobalData. This report is a licensed product and is not to be copied, reproduced, shared or resold in any form.
Executive Summary
OVERWEIGHT AND OBESITY - EPIDEMIOLOGY FORECAST TO 2022
Obesity is an escalating global public health
problem that has reached pandemic proportions. It
is caused by a combination of excessive caloric
intake and physical inactivity, which, in turn, leads
to excessive fat accumulation in the body,
negatively impacting health. Obesity is the major
cause of type 2 diabetes, coronary heart disease,
and ischemic stroke, which are increasing globally
(Larson and Wolk, 2006). The World Health
Organization (WHO) estimates that worldwide, 2.8
million people die each year due to obesity and its
associated comorbidities (WHO, 2013a).
Moreover, 35.8 million (2.3%) of global disability-
adjusted life years (DALYs) are caused by
overweight/obesity (WHO, 2013d). Globally, in
2008, 35% of adults ages 20 years and older were
overweight, as defined by a body mass index (BMI)
of ≥25 kg/m2 (includes all overweight and obese),
and 11% were obese (BMI ≥30 kg/m2) (WHO,
2013a; WHO, 2013c; WHO, 2013d). During 1980–
2008, the obesity prevalence almost doubled
globally. In 1980, only 5% of men and 8% of
women over the age of 20 years were obese, and
in 2008, these proportions almost doubled to 10%
for men and 14% for women, resulting in an
estimated 205 million and 297 million prevalent
cases of obesity in men and women, respectively
(WHO, 2013d).
This report provides an overview of the risk factors,
comorbidities, and the global trends for overweight
and obesity in the nine major markets (9MM) (US,
France, Germany, Italy, Spain, UK, Japan, Brazil,
and Canada). The report also includes a 10-year
epidemiology forecast of the prevalent cases of
overweight, obesity, obesity class I, obesity class
II, and obesity class III segmented by sex and age.
In addition, the report includes a 10-year forecast
of the prevalent cases of obesity-associated
comorbidities, such as diagnosed diabetes,
diagnosed hypertension, and dyslipidemia, among
adults with overweight/obesity in some of these
markets.
To forecast the prevalent cases of overweight,
obesity, obesity class I, obesity class II, and
obesity class III segmented by sex and age in
these major markets, GlobalData epidemiologists
used longitudinal historical data obtained from
country-specific, national-level studies using the
uniform diagnostic criteria specified by the WHO
for overweight (BMI = 25.00–29.99 kg/m2), obesity
(BMI = ≥30.00 kg/m2), obesity class I (BMI =
30.00–34.99 kg/m2), obesity class II (BMI = 35.00–
39.99 kg/m2), and obesity class III (BMI = ≥40.00
kg/m2), and applied regression methods to forecast
the prevalent cases (WHO, 2013c). GlobalData
epidemiologists used country-specific national or
regional studies that mirror the national population
to develop a forecast for the hypertension,
dyslipidemia, and type 2 diabetes comorbidities in
selected markets.
Overweight and Obesity - Epidemiology Forecast to 2022 3 © GlobalData. This report is a licensed product and is not to be copied, reproduced, shared or resold in any form.
OVERWEIGHT AND OBESITY - EPIDEMIOLOGY FORECAST TO 2022
Executive Summary
As shown in the below figures, GlobalData
epidemiologists forecast that the number of
prevalent cases of overweight in the 9MM will grow
by 8.70% during the forecast period, from 250.05
million cases in 2012 to 271.86 million cases by
2022. Compared with overweight, GlobalData
epidemiologists forecast a substantial growth in the
projected number of prevalent cases of obesity in
the 9MM, with a 27.5% increase during the
forecast period, from 167.39 million cases in 2012
to 213.34 million cases in 2022. Throughout the
forecast period, the US will have the most
prevalent cases of overweight and obesity, with
80.75 million cases of overweight and 112.78
million cases of obesity by 2022, followed by
Brazil, with 63.83 million cases of overweight and
26.34 million cases of obesity.
9MM, Prevalent Cases of Overweight, Ages ≥18 Years, Both Sexes, N (Millions), 2012 and 2022
9.37
17.19
17.38
17.59
18.59
20.78
26.37
63.83
80.75
91.53
198.65
271.86
9.54
14.38
16.12
16.64
18.50
23.38
24.25
48.56
78.69
89.02
191.96
250.05
0 50 100 150 200 250 300
Canada
Spain
France
Italy
UK
Germany
Japan
Brazil
US
5EU
7MM
9MM
Prevalent Cases of Overweight (N=Millions)
2012
2022
Source: GlobalData; CCHS, 2004; Charles et al., 2008; CHMS, 2010; CHMS, 2012; Flegal et al., 2010; Flegal et al., 2012; Gallus et al., 2006; Gallus et al., 2013; Gigante et al., 2011; Hauner et al., 2008; HSE, 2011; INE, 2013a; INE, 2013b; INE, 2013c; Monteiro et al., 2007; Ogden et al., 2006; Tanaka and Kokubo, 2005; WHO, 2011; WHO, 2013b; Yoshiike et al., 2002. Note: 5EU = France, Germany, Italy, Spain, and UK; 7MM = US, 5EU, and Japan; 9MM = 7MM, Brazil, and Canada
9MM, Prevalent Cases of Obesity, Ages ≥18 Years, Both Sexes, N (Millions), 2012 and 2022
4.00
5.15
9.22
9.90
11.41
15.69
18.85
26.34
60.32
112.78
177.10
213.34
3.66
4.77
6.65
7.62
8.23
12.93
16.55
19.17
49.13
87.80
140.60
167.39
0 50 100 150 200 250
Japan
Italy
Spain
Canada
France
UK
Germany
Brazil
5EU
US
7MM
9MM
Prevalent Cases of Obesity (N=Millions)
2012
2022
Source: GlobalData; CCHS, 2004; Charles et al., 2008; CHMS, 2010; CHMS, 2012; Flegal et al., 2010; Flegal et al., 2012; Gallus et al., 2006; Gallus et al., 2013; Gigante et al., 2011; Hauner et al., 2008; HSE, 2011; INE, 2013a; INE, 2013b; INE, 2013c; Monteiro et al., 2007; Tanaka and Kokubo, 2005; WHO, 2011; WHO, 2013b; Yoshiike et al., 2002. Note: 5EU = France, Germany, Italy, Spain, and UK; 7MM = US, 5EU, and Japan; 9MM = 7MM, Brazil, and Canada
The major drivers of the substantial increase in the
projected prevalence and prevalent cases of
overweight and obesity in the 9MM is both an
increased adoption of a westernized lifestyle and
an increase in the prevalence of obesity risk
factors. As modern lifestyles typically include risk
factors such as a sedentary lifestyle and physical
inactivity combined with high caloric intake, it will
be difficult for public health organizations and
policymakers to aim for effective control measures
at a population level to curtail this fast-growing
epidemic. As a result, GlobalData epidemiologists
predict that the obesity epidemic and its associated
comorbidities will continue to increase, making
them a significant threat to public health.
Overweight and Obesity - Epidemiology Forecast to 2022 4 © GlobalData. This report is a licensed product and is not to be copied, reproduced, shared or resold in any form.
OVERWEIGHT AND OBESITY - EPIDEMIOLOGY FORECAST TO 2022
Table of Contents
1 Table of Contents
1 Table of Contents .......................................................................................................................... 4
1.1 List of Tables............................................................................................................................ 8
1.2 List of Figures ........................................................................................................................ 10
2 Introduction ................................................................................................................................. 12
2.1 Catalyst .................................................................................................................................. 12
2.2 Related Reports ..................................................................................................................... 13
2.3 Upcoming Reports ................................................................................................................. 13
3 Epidemiology ............................................................................................................................... 14
3.1 Disease Overview .................................................................................................................. 14
3.2 Risk Factors and Comorbidities.............................................................................................. 15
3.2.1 Family history is a strong predictor of obesity ................................................................. 15
3.2.2 Physical inactivity is an independent predictor of obesity ................................................ 16
3.2.3 Excessive caloric intake doubles the risk for obesity ....................................................... 17
3.2.4 Hypertension is as high as 42% in obese adults ............................................................. 18
3.2.5 Dyslipidemia and type 2 diabetes are common comorbidities in obese patients ............. 19
3.3 Global Trends ........................................................................................................................ 21
3.3.1 US .................................................................................................................................. 22
3.3.2 5EU ................................................................................................................................ 24
3.3.3 Japan.............................................................................................................................. 30
3.3.4 Brazil .............................................................................................................................. 31
3.3.5 Canada ........................................................................................................................... 33
3.4 Forecast Methodology ............................................................................................................ 34
Overweight and Obesity - Epidemiology Forecast to 2022 5 © GlobalData. This report is a licensed product and is not to be copied, reproduced, shared or resold in any form.
OVERWEIGHT AND OBESITY - EPIDEMIOLOGY FORECAST TO 2022
Table of Contents
3.4.1 Sources Used ................................................................................................................. 41
3.4.2 Forecast Assumptions and Methods: Prevalent Cases of Overweight, Obesity, Obesity by
Class, and Comorbidities ................................................................................................ 48
3.4.3 Sources Not Used........................................................................................................... 65
3.5 Epidemiology Forecast of Overweight (2012–2022) ............................................................... 65
3.5.1 Prevalent Cases of Overweight....................................................................................... 65
3.5.2 Age-Specific Prevalent Cases of Overweight .................................................................. 67
3.5.3 Sex-Specific Prevalent Cases of Overweight .................................................................. 69
3.5.4 Age-Standardized Prevalence of Overweight .................................................................. 72
3.6 Epidemiology Forecast of Obesity (2012–2022) ..................................................................... 73
3.6.1 Prevalent Cases of Obesity ............................................................................................ 73
3.6.2 Age-Specific Prevalent Cases of Obesity ........................................................................ 75
3.6.3 Sex-Specific Prevalent Cases of Obesity ........................................................................ 77
3.6.4 Age-Standardized Prevalence of Obesity ....................................................................... 78
3.7 Epidemiology Forecast of Obesity Class I (2012–2022) ......................................................... 79
3.7.1 Prevalent Cases of Obesity Class I ................................................................................. 79
3.7.2 Age-Specific Prevalent Cases of Obesity Class I ............................................................ 81
3.7.3 Sex-Specific Prevalent Cases of Obesity Class I ............................................................ 83
3.7.4 Age-Standardized Prevalence of Obesity Class I ............................................................ 85
3.8 Epidemiology Forecast of Obesity Class II (2012–2022) ........................................................ 87
3.8.1 Prevalent Cases of Obesity Class II ................................................................................ 87
3.8.2 Age-Specific Prevalent Cases of Obesity Class II ........................................................... 89
3.8.3 Sex-Specific Prevalent Cases of Obesity Class II ........................................................... 91
Overweight and Obesity - Epidemiology Forecast to 2022 6 © GlobalData. This report is a licensed product and is not to be copied, reproduced, shared or resold in any form.
OVERWEIGHT AND OBESITY - EPIDEMIOLOGY FORECAST TO 2022
Table of Contents
3.8.4 Age-Standardized Prevalence of Obesity Class II ........................................................... 93
3.9 Epidemiology Forecast of Obesity Class III (2012–2022) ....................................................... 95
3.9.1 Prevalent Cases of Obesity Class III ............................................................................... 95
3.9.2 Age-Specific Prevalent Cases of Obesity Class III .......................................................... 97
3.9.3 Sex-Specific Prevalent Cases of Obesity Class III .......................................................... 99
3.9.4 Age-Standardized Prevalence of Obesity Class III ........................................................ 101
3.10 Epidemiology Forecast of Comorbidities among Adults with Overweight/Obesity (2012 and
2022).................................................................................................................................... 103
3.10.1 Prevalent Cases of Diagnosed Diabetes among Adults with Overweight/Obesity ......... 103
3.10.2 Prevalent Cases of Diagnosed Hypertension in Adults with Overweight/Obesity .......... 106
3.10.3 Prevalent Cases of Dyslipidemia among Adults with Overweight/Obesity ..................... 108
3.11 Discussion ........................................................................................................................... 111
3.11.1 Conclusions on Epidemiological Trends ....................................................................... 111
3.11.2 Limitations of the Analysis ............................................................................................ 112
3.11.3 Strengths of the Analysis .............................................................................................. 113
4 Appendix ................................................................................................................................... 114
4.1 Bibliography ......................................................................................................................... 114
4.2 About the Authors ................................................................................................................ 120
4.2.1 Epidemiologists ............................................................................................................ 120
4.2.2 Reviewers ..................................................................................................................... 120
4.2.3 Global Director of Epidemiology and Health Policy ....................................................... 121
4.2.4 Global Head of Healthcare ............................................................................................ 122
4.3 About GlobalData ................................................................................................................. 123
Overweight and Obesity - Epidemiology Forecast to 2022 7 © GlobalData. This report is a licensed product and is not to be copied, reproduced, shared or resold in any form.
OVERWEIGHT AND OBESITY - EPIDEMIOLOGY FORECAST TO 2022
Table of Contents
4.4 About EpiCast ...................................................................................................................... 123
4.5 Disclaimer ............................................................................................................................ 124
Overweight and Obesity - Epidemiology Forecast to 2022 8 © GlobalData. This report is a licensed product and is not to be copied, reproduced, shared or resold in any form.
OVERWEIGHT AND OBESITY - EPIDEMIOLOGY FORECAST TO 2022
Table of Contents
1.1 List of Tables
Table 1: The WHO Classification System of Adult Overweight and Obesity According to BMI .................... 14
Table 2: Risk Factors and Comorbidities of Obesity ................................................................................... 15
Table 3: 9MM, Age-Adjusted and Crude Prevalence (%) of Obesity, by Sex, Ages ≥20 Years, 2008 .......... 22
Table 4: JASSO and WHO Classifications of Obesity ................................................................................. 30
Table 5: Sources of Epidemiological Data Used for Forecasting the Prevalent Cases of Overweight .......... 35
Table 6: Sources of Epidemiological Data Used for Forecasting the Prevalent Cases of Obesity ................ 36
Table 7: Sources of Epidemiological Data Used for Forecasting the Prevalent Cases of Obesity Class I,
Class II, and Class III ................................................................................................................... 38
Table 8: Sources of Epidemiological Data Used for Forecasting the Prevalent Cases of Comorbidities in
Overweight/Obese ....................................................................................................................... 40
Table 9: 9MM, Prevalent Cases of Overweight, Ages ≥18 Years, Both Sexes, N (Millions), 2012–2022 ...... 66
Table 10: 9MM, Prevalent Cases of Overweight, By Age, Both Sexes, N (Millions), Row (%), 2012.............. 68
Table 11: 9MM, Prevalent Cases of Overweight, Ages ≥18 Years, By Sex, N (Millions), Row (%), 2012 ....... 70
Table 12: 9MM, Prevalent Cases of Obesity, Ages ≥18 Years, Both Sexes, N (Millions), 2012–2022 ........... 74
Table 13: 9MM, Prevalent Cases of Obesity, By Age, Both Sexes, N (Millions), Row (%), 2012 ................... 76
Table 14: 9MM, Prevalent Cases of Obesity, Ages ≥18 Years, by Sex, N (Millions), Row (%), 2012 ............. 77
Table 15: 9MM, Prevalent Cases of Obesity Class I, Ages ≥18 Years, Both Sexes, N (Millions), 2012–
2022 ............................................................................................................................................ 80
Table 16: 9MM, Prevalent Cases of Obesity Class I, by Age, Both Sexes, N (Millions), Row (%), 2012 ........ 82
Table 17: 9MM, Prevalent Cases of Obesity Class I, Ages ≥18 Years, By Sex, N (Millions), Row (%), 2012 . 84
Table 18: 9MM, Prevalent Cases of Obesity Class II, Ages ≥18 Years, Both Sexes, N (Millions), 2012–
2022 ............................................................................................................................................ 88
Table 19: 9MM, Prevalent Cases of Obesity Class II, By Age, Both Sexes, N (Millions), Row (%), 2012 ....... 90
Table 20: 9MM, Prevalent Cases of Obesity Class II, Ages ≥18 Years, By Sex, N (Millions), Row (%),
2012 ............................................................................................................................................ 92
Overweight and Obesity - Epidemiology Forecast to 2022 9 © GlobalData. This report is a licensed product and is not to be copied, reproduced, shared or resold in any form.
OVERWEIGHT AND OBESITY - EPIDEMIOLOGY FORECAST TO 2022
Table of Contents
Table 21: 9MM, Prevalent Cases of Obesity Class III, Ages ≥18 Years, Both Sexes, N (Millions), 2012–
2022 ............................................................................................................................................ 96
Table 22: 9MM, Prevalent Cases of Obesity Class III, By Age, Both Sexes, N (Millions), Row (%), 2012 ...... 98
Table 23: 9MM, Prevalent Cases of Obesity Class III, Ages ≥18 Years, By Sex, N (Millions), Row (%),
2012 .......................................................................................................................................... 100
Table 24: 5MM*, Prevalent Cases of Diagnosed Diabetes among Adults with Overweight/Obesity, Both
Sexes, N (Millions), 2012 and 2022 ............................................................................................ 104
Table 25: 6MM*, Prevalent Cases of Diagnosed Hypertension among Adults with Overweight/Obesity,
Both Sexes, N (Millions), 2012 and 2022 .................................................................................... 107
Table 26: 4MM, Prevalent Cases of Dyslipidemia* among Adults with Overweight/Obesity, Both Sexes, N
(Millions), 2012 and 2022 ........................................................................................................... 109
Overweight and Obesity - Epidemiology Forecast to 2022 10 © GlobalData. This report is a licensed product and is not to be copied, reproduced, shared or resold in any form.
OVERWEIGHT AND OBESITY - EPIDEMIOLOGY FORECAST TO 2022
Table of Contents
1.2 List of Figures
Figure 1: US, Overweight and Obesity Age-Adjusted Prevalence (%), Ages 20–74 Years, Men, 1960–
2010 ............................................................................................................................................ 23
Figure 2: US, Overweight and Obesity Age-Adjusted Prevalence (%), Ages 20–74 Years, Women, 1960–
2010 ............................................................................................................................................ 23
Figure 3: France, Overweight and Obesity Prevalence (%), Ages ≥15 Years, Men, 1997–2006 ................... 25
Figure 4: France, Overweight and Obesity Prevalence (%), Ages ≥15 Years, Women, 1997–2006 .............. 25
Figure 5: Italy, Overweight and Obesity Prevalence (%), Ages ≥18, Men, 1983–2010 ................................. 27
Figure 6: Italy, Overweight and Obesity Prevalence (%), Ages ≥18, Men, 1983–2010 ................................. 27
Figure 7: UK, Overweight and Obesity Prevalence (%), Ages ≥16 Years, Men, 1993–2011 ......................... 29
Figure 8: UK, Overweight and Obesity Prevalence (%), Ages ≥16 Years, Women, 1993–2011 .................... 29
Figure 9: Japan, Obesity Prevalence (%), Ages ≥20 Years, By Sex, 1976–2006 ......................................... 31
Figure 10: Brazil, Overweight and Obesity Prevalence (%), Ages ≥20 Years, Men, 1975–2003 ..................... 32
Figure 11: Brazil, Overweight and Obesity Prevalence (%), Ages ≥20 Years, Women, 1975–2003 ................ 32
Figure 12: Canada, Obesity Prevalence (%), Ages ≥18 Years, Both Sexes, 1978–2008 ................................ 34
Figure 13: 9MM, Prevalent Cases of Overweight, Ages ≥18 Years, Both Sexes, N (Millions), 2012–2022 ...... 67
Figure 14: 9MM, Prevalent Cases of Overweight, by Age, Both Sexes, N (Millions), 2012 ............................. 69
Figure 15: 9MM, Prevalent Cases of Overweight, Ages ≥18 Years, by Sex, N (Millions), 2012 ...................... 71
Figure 16: 9MM, Overweight Age-Standardized Prevalence (%), Ages ≥18 Years, By Sex, 2012 .................. 73
Figure 17: 9MM, Prevalent Cases of Obesity, Ages ≥18 Years, Both Sexes, N (Millions), 2012–2022 ........... 75
Figure 18: 9MM, Prevalent Cases of Obesity, By Age, Both Sexes, N (Millions), 2012 ................................... 76
Figure 19: 9MM, Prevalent Cases of Obesity, Ages ≥18 Years, by Sex, N (Millions), 2012 ............................ 78
Figure 20: 9MM, Obesity Age-Standardized Prevalence (%), Ages ≥18 Years, By Sex, 2012 ........................ 79
Figure 21: 9MM*, Prevalent Cases of Obesity Class I, Ages ≥18 Years, Both Sexes, N (Millions), 2012–
2022 ............................................................................................................................................ 81
Overweight and Obesity - Epidemiology Forecast to 2022 11 © GlobalData. This report is a licensed product and is not to be copied, reproduced, shared or resold in any form.
OVERWEIGHT AND OBESITY - EPIDEMIOLOGY FORECAST TO 2022
Table of Contents
Figure 22: 9MM*, Prevalent Cases of Obesity Class I, By Age, Both Sexes, N (Millions), 2012 ...................... 83
Figure 23: 9MM*, Prevalent Cases of Obesity Class I, Ages ≥18 Years, by Sex, N (Millions), 2012 ............... 85
Figure 24: 9MM*, Obesity Class I Age-Standardized Prevalence (%), Ages ≥18 Years, by Sex, 2012.......... 86
Figure 25: 9MM*, Prevalent Cases of Obesity Class II, Ages ≥18 Years, Both Sexes, N (Millions), 2012–
2022 ............................................................................................................................................ 89
Figure 26: 9MM*, Prevalent Cases of Obesity Class II, By Age, Both Sexes, N (Millions), 2012 ..................... 91
Figure 27: 9MM*, Prevalent Cases of Obesity Class II, Ages ≥18 Years, by Sex, N (Millions), 2012 .............. 93
Figure 28: 9MM*, Age-Standardized Prevalence (%) of Obesity Class II, Ages ≥18 Years, By Sex, 2012 .... 94
Figure 29: 9MM*, Prevalent Cases of Obesity Class III, Ages ≥18 Years, Both Sexes, N (Millions), 2012–
2022 ............................................................................................................................................ 97
Figure 30: 9MM*, Prevalent Cases of Obesity Class III, By Age, Both Sexes, N (Millions), 2012 .................... 99
Figure 31: 9MM*, Prevalent Cases of Obesity Class III, Ages ≥18 Years, By Sex, N (Millions), 2012 ........... 101
Figure 32: 9MM*, Obesity Class III Age-Standardized Prevalence (%), Ages ≥18 Years, By Sex, 2012 ....... 102
Figure 33: 5MM*, Prevalent Cases of Diagnosed Diabetes among Adults with Overweight/Obesity, Both
Sexes, N (Millions), 2012 ........................................................................................................... 105
Figure 34: 6MM*, Prevalent Cases of Diagnosed Hypertension among Adults with Overweight/Obesity,
Both Sexes, N (Millions), 2012 ................................................................................................... 108
Figure 35: 4MM*, Prevalent Cases of Dyslipidemia** among Adults with Overweight/Obesity, Both Sexes,
N (Millions), 2012 ....................................................................................................................... 110
Overweight and Obesity - Epidemiology Forecast to 2022 12 © GlobalData. This report is a licensed product and is not to be copied, reproduced, shared or resold in any form.
OVERWEIGHT AND OBESITY - EPIDEMIOLOGY FORECAST TO 2022
Introduction
2 Introduction
2.1 Catalyst
Overweight and obesity are diseases characterized by abnormal or excessive fat accumulation in
the body, which can increase the likelihood of developing type 2 diabetes and cardiovascular
diseases (Larson and Wolk, 2006; WHO, 2013a). The World Health Organization (WHO) classifies
overweight and obesity by body mass index (BMI). A BMI of ≥25 kg/m2 is considered overweight,
and a BMI of ≥30 kg/m2 is considered to be obese (WHO, 2013c). Obesity is an escalating public
health problem with an increasing prevalence worldwide, and it has become a well-known threat to
public health (WHO, 2013d).
To provide a thorough description of the overweight and obese (all obese, class I obesity, class
II obesity, class III obesity) patient population in each country, GlobalData epidemiologists
segmented the overweight and obesity prevalent cases by sex, age (in five-year increments,
beginning at age 18 years and ending at ≥85 years) in the nine major markets (9MM) (US,
France, Germany, Italy, Spain, UK, Japan, Brazil, and Canada).
GlobalData epidemiologists forecast that there were 250.05 million prevalent cases of
overweight adults in the 9MM in 2012, which will increase to 271.86 million cases in 2022,
increasing at an Annual Growth Rate (AGR) of 0.86%.
GlobalData epidemiologists forecast that there were 167.39 million prevalent cases of obesity
in the 9MM in 2012, which will increase to 213.34 million cases in 2022, increasing at an AGR
of 2.75%.
While the trend in the prevalent cases of overweight remains almost stable for most of the
9MM during the forecast period, a substantial growth in the prevalent cases of obesity is seen
in most of the markets.
Approximately 57% of the 250.05 million prevalent cases of overweight adults in the 9MM in
2012 were in men.
Approximately 52% of the 167.39 million prevalent cases of obese adults in the 9MM in 2012
were in women.
Overweight and Obesity - Epidemiology Forecast to 2022 123 © GlobalData. This report is a licensed product and is not to be copied, reproduced, shared or resold in any form.
OVERWEIGHT AND OBESITY - EPIDEMIOLOGY FORECAST TO 2022
Appendix
4.3 About GlobalData
GlobalData is a leading global provider of business intelligence in the Healthcare industry.
GlobalData provides its clients with up-to-date information and analysis on the latest developments
in drug research, disease analysis, and clinical research and development. Our integrated business
intelligence solutions include a range of interactive online databases, analytical tools, reports and
forecasts. Our analysis is supported by a 24/7 client support and analyst team.
GlobalData has offices in New York, Boston, London, India and Singapore.
4.4 About EpiCast
EpiCast is a series of premier epidemiology reports written and developed by Masters
and PhD level epidemiologists.
EpiCast Reports are in-depth, high quality, transparent and market-driven, providing expert
analysis of epidemiological trends and forecasting of patient populations for major markets.
Specifically, the reports identify disease trends over a 10-year forecast period in six to seven major
markets (US, France, Germany, Italy, Spain, UK, Japan). Additional countries, such as Canada,
Brazil, India and China, are covered in these reports if their markets are highly relevant.
Overweight and Obesity - Epidemiology Forecast to 2022 124 © GlobalData. This report is a licensed product and is not to be copied, reproduced, shared or resold in any form.
OVERWEIGHT AND OBESITY - EPIDEMIOLOGY FORECAST TO 2022
Appendix
4.5 Disclaimer
All Rights Reserved.
No part of this publication may be reproduced, stored in a retrieval system or transmitted in any
form by any means, electronic, mechanical, photocopying, recording or otherwise, without the prior
permission of the publisher, GlobalData.